Status:
UNKNOWN
Efficacy, Safety and Adherence of Patients Infected With Hepatitis C Virus in Retreat With INFERGEN (Interferon Alfacon1)
Lead Sponsor:
Closter Pharma
Conditions:
Hepatitis C
Eligibility:
All Genders
18+ years
Brief Summary
This is a Phase 4, descriptive, observational, open, prospective study of patients who their doctor prescribes INFERGEN for clinical practice. No medication was provided by the sponsor. The planned ob...
Eligibility Criteria
Inclusion
- Inclusion Criteria:
- Willing to consent to data being collected
- Considered by the investigator as an appropriate patient for treatment with INFERGEN in retreatment.
Exclusion
Key Trial Info
Start Date :
September 1 2011
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
August 1 2013
Estimated Enrollment :
40 Patients enrolled
Trial Details
Trial ID
NCT01426204
Start Date
September 1 2011
End Date
August 1 2013
Last Update
August 31 2011
Active Locations (0)
Enter a location and click search to find clinical trials sorted by distance.
No Results Found
We couldn’t find results for the location/zipcode entered or within the selected range. Please check your input or adjust your search.